Cite
HARVARD Citation
Baramidze, A. et al. (n.d.). 168P Liver metastases (mets) and treatment effect of cemiplimab-based therapy: An analysis from three phase III trials (EMPOWER-Lung 1, EMPOWER-Lung 3 part 2, and EMPOWER-Cervical 1). Immuno-oncology technology. p. . [Online].